Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: rituximab

2014 ACR/ARHP Annual Meeting: Fibrotic Complications of Scleroderma

Mary Beth Nierengarten  |  February 1, 2015

Rheumatology experts discuss challenge of selecting appropriate SSc patients with skin fibrosis for treatment

Filed under:ConditionsMeeting ReportsSystemic Sclerosis Tagged with:2014 ACR/ARHP Annual MeetingAC&RAssociation of Rheumatology Professionals (ARP)NierengartenSclerodermaTreatment

2014 ACR/ARHP Annual Meeting: Lupus Nephritis

Mary Beth Nierengarten  |  February 1, 2015

Multi-targeted, aggressive drug therapies needed for complete response, remission of this lupus complication

Filed under:ConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:2014 ACR/ARHP Annual MeetingAC&RAssociation of Rheumatology Professionals (ARP)drugLupus nephritis

Has Technology Depersonalized the Art of Medical Teaching?

Simon M. Helfgott, MD  |  February 1, 2015

Video streaming, interactive learning, flipped classrooms, self-study replacing class lectures

Filed under:Education & TrainingOpinionRheuminationsSpeak Out Rheum Tagged with:Helfgottlecturemedical teachingTechnologyvideo streaming

Hepatitis C Virus Infection Associated with Rheumatoid Arthritis

Lara C. Pullen, PhD  |  January 23, 2015

Research finds patients with chronic HCV infection more likely to develop RA, especially men

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:hepatitis B virusResearchRheumatoid arthritis

Biomarkers to Guide Diagnosis, Treatment of Rheumatic Diseases

Rick Brasington, MD  |  January 1, 2015

Examining the usefulness, drawbacks of current biomarkers in rheumatology and progress to develop better ones

Filed under:ConditionsRheumatoid Arthritis Tagged with:BiomarkersClinicalDr. Richard Brasington Jr.patient careRheumatic DiseaseRheumatoid arthritis

Vaccines and Biologics: What Rheumatologists Need to Know

Kurt Ullman  |  December 1, 2014

How vaccines, medications and rheumatic disease-related effects on immune system interact

Filed under:Biologics/DMARDsDrug UpdatesResearch Rheum Tagged with:BiologicsImmune SysteminteractionResearchRheumatic DiseaserheumatologistrheumatologyrituximabUllmanvaccines

Cure, Effective Treatment for Lupus Nephritis Remain Elusive Despite Advances

Elena M. Massarotti, MD, & Peter H. Schur, MD  |  December 1, 2014

Rheumatology experts review history of LN, offer explanations for roadblocks to better therapies

Filed under:ConditionsDrug UpdatesResearch RheumSystemic Lupus Erythematosus Tagged with:curedrugLupusLupus nephritisPainprednisoneResearchrheumatologistrheumatologySchurSteroidsTreatment

Systemic Sjögrens: More Than a Sicca Disease

Pilar Brito-Zerón, MD, PhD, and Manuel Ramos-Casals, MD, PhD, on behalf of the EULAR-SS Task Force Group  |  November 1, 2014

Differences in its epidemiologic, clinical and immunologic features underscore need for a homogeneous diagnostic and therapeutic approach

Filed under:ConditionsOther Rheumatic ConditionsPain SyndromesRheumatoid ArthritisSjögren’s DiseaseSoft Tissue PainSystemic Lupus Erythematosus Tagged with:EULARFibromyalgiaIgG4 related diseaseRheumatoid arthritissiccaSjogren'sSystemic lupus erythematosus

Rheumatology Research Foundation’s Annual Investigators’ Meeting Spotlights Latest Findings

From the College, with Jeffrey Sparks, MD, MMSc  |  October 1, 2014

Groundbreaking research in treatments for rheumatoid arthritis, inflammatory disease discussed at Foundation’s celebrated event

Filed under:ConditionsFrom the CollegeMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:ResearchRheumatology Research Foundation

Atacicept, Mavrilimumab Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  September 1, 2014

Plus, rheumatology drug news, safety updates

Filed under:Biologics/DMARDsConditionsDrug UpdatesResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:ataciceptBiologicsdrugKaufmanmavrilimumabResearchRheumatoid arthritisrheumatologistrheumatologyrituximabSafetySystemic lupus erythematosus

  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 45
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences